Li X, Zeng F, Yue R, Ma D, Meng Z, Li Q
Vaccines (Basel). 2024; 12(2).
PMID: 38400104
PMC: 10891849.
DOI: 10.3390/vaccines12020120.
Mungmunpuntipantip R, Wiwanitkit V
Int J Prev Med. 2024; 14:112.
PMID: 38264556
PMC: 10803678.
DOI: 10.4103/ijpvm.ijpvm_146_22.
Wang Y, Cheng S, Shen C, Huang S, Cheng C
Clin Exp Vaccine Res. 2023; 12(4):337-345.
PMID: 38025918
PMC: 10655154.
DOI: 10.7774/cevr.2023.12.4.337.
Li H, Ping F, Li X, Wang Z, Xiao J, Jiang H
Front Endocrinol (Lausanne). 2023; 14:1172089.
PMID: 37334292
PMC: 10270113.
DOI: 10.3389/fendo.2023.1172089.
Ash N, Triki N, Waitzberg R
Isr J Health Policy Res. 2023; 12(1):13.
PMID: 37072814
PMC: 10112313.
DOI: 10.1186/s13584-023-00564-x.
Humoral response after a fourth dose of SARS-CoV-2 vaccine in immunocompromised patients. Results of a systematic review.
Martinelli S, Pascucci D, Laurenti P
Front Public Health. 2023; 11:1108546.
PMID: 37033069
PMC: 10076800.
DOI: 10.3389/fpubh.2023.1108546.
A Seroprevalence Study on Residents in a Senior Care Facility with Breakthrough SARS-CoV-2 Omicron Infection.
Kim H, Lee E, O S, Choi Y, Lee H, Oh S
Viral Immunol. 2023; 36(3):203-208.
PMID: 36951666
PMC: 10621659.
DOI: 10.1089/vim.2022.0133.
COVID-19 Booster Vaccination Bellwethers: Factors Predictive of Older Adults' Adoption of the Second Booster COVID-19 Vaccine in Israel: A Longitudinal Study.
Ben-David B, Keisari S, Regev T, Palgi Y
J Appl Gerontol. 2023; 42(5):1113-1117.
PMID: 36794638
PMC: 9941450.
DOI: 10.1177/07334648221145837.
Attitudes of healthcare workers and members of the public toward the COVID-19 vaccine: A cross-sectional survey.
Ramot S, Tal O
Hum Vaccin Immunother. 2022; 18(6):2124782.
PMID: 36314896
PMC: 9746361.
DOI: 10.1080/21645515.2022.2124782.
Evolutionary Pattern Comparisons of the SARS-CoV-2 Delta Variant in Countries/Regions with High and Low Vaccine Coverage.
Zhang J, Fan L, Xu H, Fu Y, Peng X, Zheng Y
Viruses. 2022; 14(10).
PMID: 36298851
PMC: 9611485.
DOI: 10.3390/v14102296.
Unraveling the dynamics of the Omicron and Delta variants of the 2019 coronavirus in the presence of vaccination, mask usage, and antiviral treatment.
Ngonghala C, Taboe H, Safdar S, Gumel A
Appl Math Model. 2022; 114:447-465.
PMID: 36281307
PMC: 9581714.
DOI: 10.1016/j.apm.2022.09.017.
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients.
Becker M, Cossmann A, Lurken K, Junker D, Gruber J, Juengling J
Front Immunol. 2022; 13:1004045.
PMID: 36275672
PMC: 9582343.
DOI: 10.3389/fimmu.2022.1004045.
Expected cost effectiveness of the fourth dose of COVID-19 vaccine against the omicron variant of COVID-19: a preliminary report.
Mungmunpuntipantip R, Wiwanitkit V
Int J Physiol Pathophysiol Pharmacol. 2022; 14(4):272-275.
PMID: 36161259
PMC: 9490214.
Rapid Evaluation of Vaccine Booster Effectiveness against SARS-CoV-2 Variants.
Cheng H, Lim S, Jia H, Chen M, Ng S, Gao X
Microbiol Spectr. 2022; 10(5):e0225722.
PMID: 36069616
PMC: 9602425.
DOI: 10.1128/spectrum.02257-22.
Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines.
Bell E, Brassel S, Oliver E, Schirrmacher H, Arnetorp S, Berg K
Vaccines (Basel). 2022; 10(8).
PMID: 36016208
PMC: 9414589.
DOI: 10.3390/vaccines10081320.
COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects.
Zarebska-Michaluk D, Hu C, Brzdek M, Flisiak R, Rzymski P
Vaccines (Basel). 2022; 10(8).
PMID: 36016111
PMC: 9412973.
DOI: 10.3390/vaccines10081223.
Association of Receiving a Fourth Dose of the BNT162b Vaccine With SARS-CoV-2 Infection Among Health Care Workers in Israel.
Cohen M, Oster Y, Moses A, Spitzer A, Benenson S
JAMA Netw Open. 2022; 5(8):e2224657.
PMID: 35917125
PMC: 9346545.
DOI: 10.1001/jamanetworkopen.2022.24657.
Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys.
Chadeau-Hyam M, Tang D, Eales O, Bodinier B, Wang H, Jonnerby J
Lancet Reg Health Eur. 2022; 21:100462.
PMID: 35915784
PMC: 9330654.
DOI: 10.1016/j.lanepe.2022.100462.
RNA Viruses, Pregnancy and Vaccination: Emerging Lessons from COVID-19 and Ebola Virus Disease.
Dhanya C, Shailaja A, Mary A, Kandiyil S, Savithri A, Lathakumari V
Pathogens. 2022; 11(7).
PMID: 35890044
PMC: 9322689.
DOI: 10.3390/pathogens11070800.
At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant.
Singanallur N, van Vuren P, McAuley A, Bruce M, Kuiper M, Gwini S
Front Immunol. 2022; 13:883612.
PMID: 35655773
PMC: 9152325.
DOI: 10.3389/fimmu.2022.883612.
